Physician profile
Justin Brown
NPI 1740375310
$21,044.24
in general payments reported to CMS, 2019-2025
44 companies · $4,268 in 2025
The $4,268 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,122 · 2020: $1,621 · 2021: $2,208 · 2022: $3,226 · 2023: $3,650 · 2024: $3,950 · 2025: $4,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,174.71 |
| Education | $693.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,592.92 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $2,828.87 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Leo Pharma INC. | $2,089.08 | 2019-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $1,711.44 | 2019-2025 | Winlevi, Ilumya, Blu-U |
| Lilly USA, LLC | $1,116.06 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $1,076.28 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,053.13 | 2019-2025 | Aklief, Nemluvio, Epsolay |
| Incyte Corporation | $921.58 | 2021-2025 | Opzelura |
| Pfizer INC. | $916.09 | 2019-2025 | |
| Genzyme Corporation | $759.28 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $588.45 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $574.02 | 2019-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $478.33 | 2022-2025 | Sotyktu |
| Ucb, INC. | $403.62 | 2019-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $350.68 | 2023-2024 | Vtama |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.